Mittie Doyle Insider Trades & Stock Holdings

Chief Medical Officer · Avalo Therapeutics, Inc. · Latest filing Jun 23, 2026

Mittie Doyle, Chief Medical Officer at Avalo Therapeutics, Inc. has 3 Form 4 trades on file since Jun 16, 2026 across 2 companies. Latest filing: disposed of 1.45K shares of $AVTX on Jun 23, 2026.

Trades on file

3

Open-market bought

$0

Open-market sold

$0

Net open-market

$0

Latest filing

Jun 23, 2026

All insider trades by Mittie Doyle

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 23, 2026	$AVTX	Sell (Option exercise)	1.45K	$0	—			+3.6%	-0.4%		Chief Medical Officer		—
Jun 23, 2026	$AVTX	Buy (Option exercise)	1.45K	$8.04	$11.66K			+3.6%	-0.4%		Chief Medical Officer		Read
Jun 16, 2026	$CGEM	Buy (Grant or award)	21.78K	$0	—			+31.0%	+21.1%				Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Mittie Doyle traded

• $AVTX
• $CGEM

Frequently asked questions

What was Mittie Doyle's latest insider trade?

disposed of 1.45K shares of $AVTX on Jun 23, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.